OTC Healthcare in the US to 2011
Datamonitor
August 11, 2008 159 Pages - SKU: DFMN1872805
|
|
Countries covered: United States
Introduction
This databook is a detailed information resource covering all the key data points on OTC Healthcare in the US. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011.
Scope- Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
- Provides market value, volume, expenditure and consumption data by market, segment and subsegment
- Includes company and brand share data by categories
Highlights
The market for OTC Healthcare in the US increased between 2001-2006, growing at an average annual rate of 3.1%.
The leading company in the market in 2006 was Pfizer Inc. The second-largest player was Wyeth with GlaxoSmithKline Plc in third place.
Reasons to Purchase- Discover the major quantitative trends affecting the OTC Healthcare markets
- Understand consumers' consumption and expenditure patterns
- Understand the future direction of the market with reliable historical data and full five year forecasting
|
Additional InformationDatabooks are a detailed information resource covering all the key data points across all industry verticals. They provide data covering a particular market at country or regional level in comprehensive tabular and brief contextual format. The databook allows the user to study and analyze the data. This databook is comprised of an overview chapter covering the market as a whole, a chapter examining each category within the market, and a chapter containing socioeconomic analysis and data. It also includes a chapter detailing Datamonitor’s research methodology, and an appendix containing additional details.
- Chapter 1 EXECUTIVE SUMMARY
- Summary Market Level - OTC Healthcare
- Summary category level - Analgesics
- Summary category level - Cough and Cold Preparations
- Summary category level - Traditional Medicines
- Summary category level - First Aid Kits
- Summary category level - Indigestion Preparations
- Summary category level - Vitamins and Minerals
- Summary category level - Plasters & Bandages
- Summary category level - Medicated Skin Products
- Summary category level - Other OTC Healthcare Products
- Summary category level - Topical OTC Medicines
- Chapter 2 INTRODUCTION
- What is this report about?
- How to use this report
- Market Definition
- Chapter 3 MARKET OVERVIEW
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 4 LEADING COMPANY PROFILES
- Pfizer Inc
- Wyeth
- Chapter 5 CATEGORY ANALYSIS - ANALGESICS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES
- Value Analysis, 2001-2006
- Value Analysis, 2006-2011
- Company and Brand Share Analysis
- Expenditure & consumption per capita
- Chapter 15 COUNTRY COMPARISON
- Value
- Market Share
- Chapter 16 NEW PRODUCT DEVELOPMENT
- Product launches over time
- Recent product launches
- Chapter 17 US SOCIOECONOMIC PROFILE
- Country Overview
- Key Facts
- Political Overview
- US Economic Overview
- Chapter 18 US MACROECONOMIC PROFILE
- Macroeconomic Indicators
- Chapter 19 RESEARCH METHODOLOGY
- Methodology overview
- Secondary research
- Market modelling
- Primary research
- Data finalisation
- Ongoing research
- Chapter 20 APPENDIX
- Future readings
- How to contact experts in your industry
- LIST OF FIGURES
- Figure 1: US OTC Healthcare value & value forecast, 2001-2011 (USD m, nominal prices)
- Figure 2: US OTC Healthcare category growth comparison, by value, 2001-2011
- Figure 3: US OTC Healthcare company share, by value, 2005-2006 (%)
- Figure 4: US Analgesics value & value forecast, 2001-2011 (USD m, nominal prices)
- Figure 5: US Analgesics category growth comparison, by value, 2001-2011
- Figure 6: US Analgesics company share, by value, 2005-2006 (%)
- Figure 7: US Cough and Cold Preparations value & value forecast, 2001-2011 (USD m, nominal prices)
- Figure 8: US Cough and Cold Preparations category growth comparison, by value, 2001-2011
- Figure 9: US Cough and Cold Preparations company share, by value, 2005-2006 (%)
- Figure 10: US Traditional Medicines value & value forecast, 2001-2011 (USD m, nominal prices)
- Figure 11: US First Aid Kits value & value forecast, 2001-2011 (USD m, nominal prices)
- Figure 12: US First Aid Kits company share, by value, 2005-2006 (%)
- Figure 13: US Indigestion Preparations value & value forecast, 2001-2011 (USD m, nominal prices)
- Figure 14: US Indigestion Preparations category growth comparison, by value, 2001-2011
- Figure 15: US Indigestion Preparations company share, by value, 2005-2006 (%)
- Figure 16: US Vitamins and Minerals value & value forecast, 2001-2011 (USD m, nominal prices)
- Figure 17: US Vitamins and Minerals category growth comparison, by value, 2001-2011
- Figure 18: US Vitamins and Minerals company share, by value, 2005-2006 (%)
- Figure 19: US Plasters & Bandages value & value forecast, 2001-2011 (USD m, nominal prices)
- Figure 20: US Plasters & Bandages category growth comparison, by value, 2001-2011
- Figure 21: US Plasters & Bandages company share, by value, 2005-2006 (%)
- Figure 22: US Medicated Skin Products value & value forecast, 2001-2011 (USD m, nominal prices)
- Figure 23: US Medicated Skin Products category growth comparison, by value, 2001-2011
- Figure 24: US Medicated Skin Products company share, by value, 2005-2006 (%)
- Figure 25: US Other OTC Healthcare Products value & value forecast, 2001-2011 (USD m, nominal prices)
- Figure 26: US Other OTC Healthcare Products category growth comparison, by value, 2001-2011
- Figure 27: US Other OTC Healthcare Products company share, by value, 2005-2006 (%)
- Figure 28: US Topical OTC Medicines value & value forecast, 2001-2011 (USD m, nominal prices)
- Figure 29: US Topical OTC Medicines category growth comparison, by value, 2001-2011
- Figure 30: Global OTC Healthcare market split (value terms, 2006) - Top 5 countries
- Figure 31: Global OTC Healthcare market value, 2001 - 2006 (Top 5 countries)
- Figure 32: Map of the US
- Figure 33: Annual data review process
- LIST OF TABLES
- Table 1: OTC Healthcare category definitions
- Table 2: US OTC Healthcare value, 2001-2006 (USD m, nominal prices)
- Table 3: US OTC Healthcare value forecast, 2006-2011 (USD m, nominal prices)
- Table 4: US OTC Healthcare brand share, by value, 2005-2006 (%)
- Table 5: US OTC Healthcare value, by brand 2005-2006 (USD m nominal prices)
- Table 6: US OTC Healthcare company share by value, 2005-2006 (%)
- Table 7: US OTC Healthcare value, by company, 2005-2006 (USD m nominal prices)
- Table 8: US OTC Healthcare expenditure per capita, 2001-2006 (USD, nominal prices)
- Table 9: US OTC Healthcare forecast expenditure per capita, 2006-2011 (USD, nominal prices)
- Table 10: Pfizer Inc Key Facts
- Table 11: Wyeth Key Facts
- Table 12: US Analgesics value, 2001-2006 (USD m, nominal prices)
- Table 13: US Analgesics value forecast, 2006-2011 (USD m, nominal prices)
- Table 14: US Analgesics brand share, by value, 2005-2006 (%)
- Table 15: US Analgesics value, by brand 2005-2006 (USD m nominal prices)
- Table 16: US Analgesics company share by value, 2005-2006 (%)
- Table 17: US Analgesics value, by company, 2005-2006 (USD m nominal prices)
- Table 18: US Analgesics expenditure per capita, 2001-2006 (USD, nominal prices)
- Table 19: US Analgesics forecast expenditure per capita, 2006-2011 (USD, nominal prices)
- Table 20: US Cough and Cold Preparations value, 2001-2006 (USD m, nominal prices)
- Table 21: US Cough and Cold Preparations value forecast, 2006-2011 (USD m, nominal prices)
- Table 22: US Cough and Cold Preparations brand share, by value, 2005-2006 (%)
- Table 23: US Cough and Cold Preparations value, by brand 2005-2006 (USD m nominal prices)
- Table 24: US Cough and Cold Preparations company share by value, 2005-2006 (%)
- Table 25: US Cough and Cold Preparations value, by company, 2005-2006 (USD m nominal prices)
- Table 26: US Cough and Cold Preparations expenditure per capita, 2001-2006 (USD, nominal prices)
- Table 27: US Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (USD, nominal prices)
- Table 28: US Traditional Medicines value, 2001-2006 (USD m, nominal prices)
- Table 29: US Traditional Medicines value forecast, 2006-2011 (USD m, nominal prices)
- Table 30: US Traditional Medicines brand share, by value, 2005-2006 (%)
- Table 31: US Traditional Medicines value, by brand 2005-2006 (USD m nominal prices)
- Table 32: US Traditional Medicines company share by value, 2005-2006 (%)
- Table 33: US Traditional Medicines value, by company, 2005-2006 (USD m nominal prices)
- Table 34: US Traditional Medicines expenditure per capita, 2001-2006 (USD, nominal prices)
- Table 35: US Traditional Medicines forecast expenditure per capita, 2006-2011 (USD, nominal prices)
- Table 36: US First Aid Kits value, 2001-2006 (USD m, nominal prices)
- Table 37: US First Aid Kits value forecast, 2006-2011 (USD m, nominal prices)
- Table 38: US First Aid Kits brand share, by value, 2005-2006 (%)
- Table 39: US First Aid Kits value, by brand 2005-2006 (USD m nominal prices)
- Table 40: US First Aid Kits company share by value, 2005-2006 (%)
- Table 41: US First Aid Kits value, by company, 2005-2006 (USD m nominal prices)
- Table 42: US First Aid Kits expenditure per capita, 2001-2006 (USD, nominal prices)
- Table 43: US First Aid Kits forecast expenditure per capita, 2006-2011 (USD, nominal prices)
- Table 44: US Indigestion Preparations value, 2001-2006 (USD m, nominal prices)
- Table 45: US Indigestion Preparations value forecast, 2006-2011 (USD m, nominal prices)
- Table 46: US Indigestion Preparations brand share, by value, 2005-2006 (%)
- Table 47: US Indigestion Preparations value, by brand 2005-2006 (USD m nominal prices)
- Table 48: US Indigestion Preparations company share by value, 2005-2006 (%)
- Table 49: US Indigestion Preparations value, by company, 2005-2006 (USD m nominal prices)
- Table 50: US Indigestion Preparations expenditure per capita, 2001-2006 (USD nominal prices)
- Table 51: US Indigestion Preparations forecast expenditure per capita, 2006-2011 (USD nominal prices)
- Table 52: US Vitamins and Minerals value, 2001-2006 (USD m, nominal prices)
- Table 53: US Vitamins and Minerals value forecast, 2006-2011 (USD m, nominal prices)
- Table 54: US Vitamins and Minerals brand share, by value, 2005-2006 (%)
- Table 55: US Vitamins and Minerals value, by brand 2005-2006 (USD m nominal prices)
- Table 56: US Vitamins and Minerals company share by value, 2005-2006 (%)
- Table 57: US Vitamins and Minerals value, by company, 2005-2006 (USD m nominal prices)
- Table 58: US Vitamins and Minerals expenditure per capita, 2001-2006 (USD, nominal prices)
- Table 59: US Vitamins and Minerals forecast expenditure per capita, 2006-2011 (USD, nominal prices)
- Table 60: US Plasters & Bandages value, 2001-2006 (USD m, nominal prices)
- Table 61: US Plasters & Bandages value forecast, 2006-2011 (USD m, nominal prices)
- Table 62: US Plasters & Bandages brand share, by value, 2005-2006 (%)
- Table 63: US Plasters & Bandages value, by brand 2005-2006 (USD m nominal prices)
- Table 64: US Plasters & Bandages company share by value, 2005-2006 (%)
- Table 65: US Plasters & Bandages value, by company, 2005-2006 (USD m nominal prices)
- Table 66: US Plasters & Bandages expenditure per capita, 2001-2006 (USD, nominal prices)
- Table 67: US Plasters & Bandages forecast expenditure per capita, 2006-2011 (USD, nominal prices)
- Table 68: US Medicated Skin Products value, 2001-2006 (USD m, nominal prices)
- Table 69: US Medicated Skin Products value forecast, 2006-2011 (USD m, nominal prices)
- Table 70: US Medicated Skin Products brand share, by value, 2005-2006 (%)
- Table 71: US Medicated Skin Products value, by brand 2005-2006 (USD m nominal prices)
- Table 72: US Medicated Skin Products company share by value, 2005-2006 (%)
- Table 73: US Medicated Skin Products value, by company, 2005-2006 (USD m nominal prices)
- Table 74: US Medicated Skin Products expenditure per capita, 2001-2006 (USD, nominal prices)
- Table 75: US Medicated Skin Products forecast expenditure per capita, 2006-2011 (USD, nominal prices)
- Table 76: US Other OTC Healthcare Products value, 2001-2006 (USD m, nominal prices)
- Table 77: US Other OTC Healthcare Products value forecast, 2006-2011 (USD m, nominal prices)
- Table 78: US Other OTC Healthcare Products brand share, by value, 2005-2006 (%)
- Table 79: US Other OTC Healthcare Products value, by brand 2005-2006 (USD m nominal prices)
- Table 80: US Other OTC Healthcare Products company share by value, 2005-2006 (%)
- Table 81: US Other OTC Healthcare Products value, by company, 2005-2006 (USD m nominal prices)
- Table 82: US Other OTC Healthcare Products expenditure per capita, 2001-2006 (USD, nominal prices)
- Table 83: US Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (USD nominal prices)
- Table 84: US Topical OTC Medicines value, 2001-2006 (USD m, nominal prices)
- Table 85: US Topical OTC Medicines value forecast, 2006-2011 (USD m, nominal prices)
- Table 86: US Topical OTC Medicines brand share, by value, 2005-2006 (%)
- Table 87: US Topical OTC Medicines value, by brand 2005-2006 (USD m nominal prices)
- Table 88: US Topical OTC Medicines company share by value, 2005-2006 (%)
- Table 89: US Topical OTC Medicines value, by company, 2005-2006 (USD m nominal prices)
- Table 90: US Topical OTC Medicines expenditure per capita, 2001-2006 (USD, nominal prices)
- Table 91: US Topical OTC Medicines forecast expenditure per capita, 2006-2011 (USD, nominal prices)
- Table 92: Global OTC Healthcare market value, 2006
- Table 93: Global OTC Healthcare market split (value terms (US$ m), 2006) - Top 5 countries
- Table 94: Leading players - Top 5 countries
- Table 95: US OTC Healthcare new product launches (reports) and SKUs, by company (Top 5 companies), 2006
- Table 96: US OTC Healthcare new product launches (reports), by flavor and fragrances (Top 10 flavors), 2006
- Table 97: US OTC Healthcare new product launches (reports), by Ingredients (Top 10 Ingredients), 2006
- Table 98: US OTC Healthcare new product launches (reports), by Package tags or Claims (Top 10 claims), 2006
- Table 99: US OTC Healthcare new product launches (reports) - Recent 5 launches
- Table 100: US Key Facts
- Table 101: US population, by age group, 2000-2005 (millions)
- Table 102: US population forecast, by age group, 2005-2010 (millions)
- Table 103: US population, by gender, 2000-2005 (millions)
- Table 104: US population forecast, by gender, 2005-2010 (millions)
- Table 105: US real GDP, 2000-2005 (USD bn, 2005 prices)
- Table 106: US real GDP forecast, 2005-2010 (USD bn, 2005 prices)
- Table 107: US nominal GDP, 2000-2005 (USD bn, nominal prices)
- Table 108: US real GDP, 2000-2005 (US$ bn, 2005 prices)
- Table 109: US real GDP forecast, 2005-2010 (US$ bn, 2005 prices)
- Table 110: US consumer price index, 2000-2005 (2000=100)
- Table 111: US consumer price index, 2005-2010 (2000=100)
- Table 112: US exchange rate, 2000-2005
More United States Over-the-Counter Drugs Reports
Medicated Skin Care in the US by
Euromonitor International
Medicated skin care continued to benefit from growing consumer demand in a variety of specialty/niche segments. Hair loss treatments, for example, continued to benefit from ...
Herbal/Traditional Products in the US by
Euromonitor International
As regulatory actions shook many non-herbal/traditional categories in 2011, herbal/traditional products was able to gain some of the lost share in categories such as cough, ...
Ear Care in the US by
Euromonitor International
In February 2012, Prestige Brands Inc announced that it had completed the acquisition of 17 OTC brands from GlaxoSmithKline Consumer Health in a US$660 million ...
Digestive Remedies in the US by
Euromonitor International
In December 2010, Johnson & Johnson’s product recall woes were majorly reinforced in digestive remedies. First, the company (in its joint venture with Merck & ...
Cough, Cold and Allergy (Hay Fever) Remedies in the US by
Euromonitor International
In 2011, Chattem Inc’s Allegra brand of antihistamine/allergy remedies (systemic) switched from Rx-to-OTC, representing one of the largest switches in the segment’s history. First stocked ...
See all reports like this >>
More United States Reports
e-Discovery Software Publishing in the US - Industry Market Research Report by
IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...
D&B Country RiskLine Report: The United States of America by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report United States January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Coal - US - a snapshot (2010) by
Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...
See all reports like this >>
Share this report
Other tasks Related Markets Over-the-Counter Drugs Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|